T-cell receptor–HLA-DRB1 associations suggest specific antigens in pulmonary sarcoidosis
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
In pulmonary sarcoidosis, CD4+T-cells expressing T-cell receptor Vα2.3 accumulate in the lungs of HLA-DRB1*03+patients. To investigate T-cell receptor-HLA-DRB1*03 interactions underlying recognition of hitherto unknown antigens, we performed detailed analyses of T-cell receptor expression on bronchoalveolar lavage fluid CD4+T-cells from sarcoidosis patients. Pulmonary sarcoidosis patients (n=43) underwent bronchoscopy with bronchoalveolar lavage. T-cell receptor α and β chains of CD4+T-cells were analysed by flow cytometry, DNA-sequenced, and three-dimensional molecular models of T-cell receptor-HLA-DRB1*03 complexes generated. Simultaneous expression of Vα2.3 with the Vβ22 chain was identified in the lungs of all HLA-DRB1*03+patients. Accumulated Vα2.3/Vβ22-expressing T-cells were highly clonal, with identical or near-identical Vα2.3 chain sequences and inter-patient similarities in Vβ22 chain amino acid distribution. Molecular modelling revealed specific T-cell receptor-HLA-DRB1*03-peptide interactions, with a previously identified, sarcoidosis-associated vimentin peptide, (Vim)429–443 DSLPLVDTHSKRTLL, matching both the HLA peptide-binding cleft and distinct T-cell receptor features perfectly. We demonstrate, for the first time, the accumulation of large clonal populations of specific Vα2.3/Vβ22 T-cell receptor-expressing CD4+T-cells in the lungs of HLA-DRB1*03+sarcoidosis patients. Several distinct contact points between Vα2.3/Vβ22 receptors and HLA-DRB1*03 molecules suggest presentation of prototypic vimentin-derived peptides.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vimentin is secreted by activated macrophages
Mor-Vaknin, N., Punturieri, A., Sitwala, K., & Markovitz, D. M. (2003) · Nature Cell Biology · doi:10.1038/ncb898 · Cited by 522
Cited by
Grunewald, J., Grutters, J. C., Arkema, E. V., Saketkoo, L. A., Moller, D. R., & Müller-Quernheim, J. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0096-x · Cited by 479
Self-citationCheng, R. K., Kittleson, M. M., Beavers, C. J., Birnie, D. H., Blankstein, R., Bravo, P. E., Gilotra, N. A., Judson, M. A., Patton, K. K., Rose-Bovino, L., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001240 · Cited by 259
Vimentin as antigenic target in autoimmunity: A comprehensive review
Musaelyan, A., Lapin, S., Nazarov, V., Tkachenko, O., Gilburd, B., Mazing, A., Mikhailova, L., & Shoenfeld, Y. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.04.004 · Cited by 111
Gilotra, N. A., GRIFFIN, J. M., PAVLOVIC, N., HOUSTON, B. A., CHASLER, J., GOETZ, C., CHRISPIN, J., SHARP, M., KASPER, E. K., CHEN, E. S., et al. (2022) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.06.016 · Cited by 94
Kidney manifestations of sarcoidosis.
Bonella, F., DM Vorselaars, A., & Wilde, B. (2024) · Journal of autoimmunity · doi:10.1016/j.jaut.2024.103207 · Cited by 32
Metadata
- Authors
- Grunewald, J., Kaiser, Y., Ostadkarampour, M., Rivera, N. V., Vezzi, F., Lötstedt, B., Olsen, R.-A., Sylwan, L., Lundin, S., Käller, M., Sandalova, T., Ahlgren, K. M., Wahlström, J., Achour, A., Ronninger, M., & Eklund, A.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2015-11-19
- Volume
- 47
- Issue
- 3
- Pages
- 898-909
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2270784795
- Cited by
- 79
- References
- 1
- FWCI
- 5.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: T-cell receptor–HLA-DRB1 associations suggest specific antigens in pulmonary sarcoidosis. https://app.cochat.ai/papers/10.1183/13993003.01209-2015
- The paper
- Grunewald, J., Kaiser, Y., Ostadkarampour, M., Rivera, N. V., Vezzi, F., Lötstedt, B., Olsen, R.-A., Sylwan, L., Lundin, S., Käller, M., Sandalova, T., Ahlgren, K. M., Wahlström, J., Achour, A., Ronninger, M., & Eklund, A. (2016). T-cell receptor–HLA-DRB1 associations suggest specific antigens in pulmonary sarcoidosis. European Respiratory Journal. https://doi.org/10.1183/13993003.01209-2015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.